Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.

Journal of the American Academy of Dermatology - 1 Aug 2023

Pezzolo Elena, Gambardella Alessio, Guanti Mario, Bianchelli Tommaso, Bertoldi Alberto, Giacchetti Alfredo, Donini Massino, Argenziano Giuseppe, Naldi Luigi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatitis, Atopic
Share to Phenotype
Share to Pruritus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Severity of Illness Index

Source

Identifiers

PMID: 37150301
DOI: 10.1016/j.jaad.2023.04.056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.PMID 37150301Read ↗

Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularisSemantic proximity Read ↗

Targeting <scp>IL</scp>‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 yearsSemantic proximity Read ↗

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsSemantic proximity Read ↗

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.Semantic proximity Read ↗

Hailey-Hailey disease successfully treated with tralokinumab and literature review of successful treatment with dupilumabSemantic proximity Read ↗

Clinical phenotypes of adult atopic dermatitis and related therapies.Semantic proximity Read ↗

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitroSemantic proximity Read ↗

The Updated Guide in the Management of Psoriasis for Every PractitionerSemantic proximity Read ↗

Chronic Hand Eczema is a Type 2 Disease: Evidences from Integrated Clinical Trial and Molecular ProfilingSemantic proximity Read ↗

Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making.Semantic proximity Read ↗

Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.Semantic proximity Read ↗

Japanese guidelines for atopic dermatitis 2017.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.